Dopamine agonists and sleep in Parkinson's disease

Neurology
Charles R Cantor, Matthew B Stern

Abstract

Dopaminergic therapy is increasingly recognized as a cause of excessive daytime sleepiness in patients with PD. This adverse effect may be a dose-related phenomenon that is somewhat more likely to occur with dopamine agonists than with levodopa, although all dopaminergic drugs can be sedating. However, medication effect is only one of several causes of somnolence in PD. Other factors include age-related changes in sleep quality, nocturnal motor disturbances, primary sleep disorders such as sleep apnea, medication-induced sleep disruption, and concurrent medical illnesses. There is also increasing evidence that the disease process itself may affect the control of the sleep-wake cycle. Although we have characterized the sleep disturbances in PD, further investigation is needed to define their prevalence and etiology, particularly with respect to the role of dopamine and dopaminergic agents. Clinicians should be alert to the complaint of excessive sleepiness in their patients and should attempt to identify and treat the underlying causes.

Citations

Mar 23, 2004·Sleep Medicine·G PaulettoP Bergonzi
Feb 4, 2010·Parkinsonism & Related Disorders·Ubaldo BonuccelliOlivier Rascol
Oct 19, 2006·Epilepsia·Daniel H Lowenstein
Aug 14, 2012·BMC Neurology·Elisabeth SvenssonBørge Sivertsen
Aug 31, 2011·Parkinson's Disease·Keisuke SuzukiKoichi Hirata
Feb 10, 2006·Expert Review of Neurotherapeutics·Ubaldo Bonuccelli, Nicola Pavese
Oct 18, 2007·Expert Review of Neurotherapeutics·Ubaldo Bonuccelli, Nicola Pavese
Jul 5, 2011·Neurología : publicación oficial de la Sociedad Española de Neurología·A Alonso CánovasJ C Martínez Castrillo
Apr 26, 2008·Journal of the Neurological Sciences·Keisuke SuzukiKoichi Hirata
Oct 27, 2007·Movement Disorders : Official Journal of the Movement Disorder Society·Dagmar VerbaanJacobus J van Hilten
Apr 8, 2006·Movement Disorders : Official Journal of the Movement Disorder Society·Juan Carlos Gómez-EstebanIker Bilbao
Sep 28, 2010·International Journal of Geriatric Psychiatry·Victoria LarssonElisabet Londos
Oct 9, 2007·Parkinsonism & Related Disorders·Peter RiedererHeinz Reichmann
Jun 25, 2005·The Journal of Chemical Physics·D B Lukatsky, Daan Frenkel
Sep 25, 2004·Movement Disorders : Official Journal of the Movement Disorder Society·Yvonne KörnerHans-Peter Krüger
Jul 27, 2004·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·H Furumoto
Feb 24, 2005·Movement Disorders : Official Journal of the Movement Disorder Society·Charlotte MeindorfnerHans-Peter Krüger

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies
S StefansdottirJ P Larsen
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
M T PellecchiaP Barone
© 2022 Meta ULC. All rights reserved